Charles Bane
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Cancer survivorship and care 1
- CAR-T cell therapy research 1
-
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Betsy LaPlant (2 shared papers)Vivek Roy (2 shared papers)Frances M. Palmieri (2 shared papers)Hongli Li (1 shared paper)Leslie Popplewell (2 shared papers)Richard I. Fisher (2 shared papers)Paul M. Barr (2 shared papers)Sonali M. Smith (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)The American Journal of Managed Care (1 paper)American Journal of Hematology (1 paper)Blood (1 paper)Quality of Life Research (1 paper)
- Partner nations
- United States
In The Last Decade
Charles Bane
6 papers receiving 171 citations
Peers
Comparison fields: 5 of 38
- Biomaterials 47
- Oncology 83
- Cancer Research 25
- Pathology and Forensic Medicine 14
- Molecular Biology 53
Countries citing papers authored by Charles Bane
This map shows the geographic impact of Charles Bane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Bane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Bane more than expected).
Fields of papers citing papers by Charles Bane
This network shows the impact of papers produced by Charles Bane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Bane. The network helps show where Charles Bane may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Bane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 120 | |
| 2 | 2017 | 42 | |
| 3 | 2015 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2007 | 3 | |
| 6 | The Oncology Medical Home—Beyond Clinical Pathways | 2016 | 1 |
About Charles Bane
Charles Bane is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 177 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer survivorship and care (1 paper), CAR-T cell therapy research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Biomaterials (47 citations), Oncology (83 citations), Cancer Research (25 citations), Pathology and Forensic Medicine (14 citations) and Molecular Biology (53 citations). Charles Bane has collaborated with scholars based in United States. Frequent co-authors include Betsy LaPlant, Vivek Roy, Frances M. Palmieri, Hongli Li, Leslie Popplewell, Richard I. Fisher, Paul M. Barr, Sonali M. Smith, Michael LeBlanc and Jonathan W. Friedberg. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Managed Care, American Journal of Hematology, Blood and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.